Please ensure Javascript is enabled for purposes of website accessibility

Aurora Cannabis Receives Another EU-GMP Certification

By Cory Renauer – Feb 3, 2020 at 12:58PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This more than triples the amount of medical marijuana that Aurora can export to Germany and the rest of the European Union.

The international expansion Aurora Cannabis (ACB 4.31%) shareholders have been waiting for took another step forward on Monday. A large marijuana production facility in Bradford, Ontario, received its European Union Good Manufacturing Practice (EU-GMP) certification.

The Aurora River site is the company's third and largest facility licensed to produce marijuana for consumption in Canada and throughout the EU. The new certification raises Aurora's ability to serve the growing market for medical marijuana in Germany and the rest of the European Union by 237% to 39,800 kilograms annually.

Medical doctor with a magic pot leaf.

Image source: Getty Images.

Making ends meet 

Aurora has quickly expanded its operations to 25 countries on three continents, and that growth hasn't come cheap. During the third quarter, funding that expansion abroad helped push Aurora's sales, general, and administration, expenses to CA$81.1 million. Meanwhile, international medical revenue grew to an annualized CA$20.0 million during the quarter, which wasn't nearly enough to cover all those added expenses. 

While an EU-GMP certification for increased capacity is a vital step on the path to significant medical marijuana sales abroad, the first two Canadian facilities to receive that green light already gave Aurora's European operation a lot of room to grow. And Aurora's German facility can produce 2,100 kilograms per year, which is probably enough capacity to meet demand in 2020 there without any imports from Canada.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.21 (4.31%) $0.05

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
327%
 
S&P 500 Returns
105%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/27/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.